Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 163 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL152314
Lundbeck Foundation
Grant: R238-2016-3349
NHLBI NIH HHS
Grant: R01 HL135607
National Institutes of Health
Grant: 5R01HL135607-02
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies
Chan Zuckerberg Initiative
NHLBI
Doris Duke Charitable Foundation
CIRM
FWCI
12.89
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals